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Abstract 
A significant challenge in environmental toxicology is that many genetic and genomic 
tools available in laboratory models are not developed for commonly used environmental 
models.  The Atlantic killifish (Fundulus heteroclitus) is one of the most studied teleost 
environmental models, yet few genetic or genomic tools have been developed for use in 
this species.  The advancement of genetic and evolutionary toxicology will require that 
many of the tools developed in laboratory models be transferred into species more 
applicable to environmental toxicology.  Antisense morpholino oligonucleotide (MO) 
gene knockdown technology has been widely utilized to study development in zebrafish 
and has been proven to be a powerful tool in toxicological investigations through direct 
manipulation of molecular pathways.  To expand the utility of killifish as an 
environmental model, MO gene knockdown technology was adapted for use in Fundulus.  
Morpholino microinjection methods were altered to overcome the significant differences 
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between these two species.  Morpholino efficacy and functional duration were evaluated 
with molecular and phenotypic methods.  A cytochrome P450-1A (CYP1A) MO was 
used to confirm effectiveness of the methodology.  For CYP1A MO-injected embryos, a 
70% reduction in CYP1A activity, a 86% reduction in total CYP1A protein, a significant 
increase in β-naphthoflavone-induced teratogenicity, and estimates of functional duration 
(50% reduction in activity 10 dpf, and 86% reduction in total protein 12 dpf) conclusively 
demonstrated that MO technologies can be used effectively in killifish and will likely be 
just as informative as they have been in zebrafish. 
 
Key words: Fundulus heteroclitus, antisense morpholino oligonucleotide, CYP1A, 
Atlantic killifish, genetic toxicology, development, teratogenesis 
 3
1.  Introduction 
The Atlantic killifish (Fundulus heteroclitus) is one of the most abundant 
estuarine fish along the Atlantic coast of the United States; as such it is ecologically very 
important (Bigelow and Schroeder, 1953, Meredith and Lotrich, 1979, Lee et al., 1980, 
Kneib, 1986, Burnett et al., 2007).  Although killifish are widespread, they have small 
home ranges, which make them ideal for studying the effects of local stressors (Lotrich, 
1975).  They are tolerant of significant changes in many environmental conditions, 
including salinity (Griffith, 1974, Wood and Marshall, 1994, Nordlie, 2006), pH 
(Gonzalez et al., 1989), temperature (Umminger, 1971, Dunson et al., 1993, Smith and 
Able, 1994, Nordlie, 2006), and oxygen (Wannamaker and Rice, 2000, Smith and Able, 
2003, Stierhoff et al., 2003, Nordlie, 2006).  Specific killifish populations have adapted to 
a variety of anthropogenic stressors, including polycyclic aromatic hydrocarbons 
(PAH)(Meyer et al., 2002, Ownby et al., 2002, Meyer and Di Giulio, 2003), 2,3,7,8-
tetrachlorodibenzo-p-dioxin (TCDD)(Prince and Cooper, 1995a, b), polychlorinated 
biphenyls (PCB)(Nacci et al., 1999, Bello et al., 2001), and mercury (Weis et al., 1981).  
For these reasons, killifish have become one of the premier teleost environmental models, 
and certainly one of the most well-studied estuarine environmental models (Burnett et al., 
2007).  While we know a great deal about killifish physiology, a lack of genomics data 
and the resulting paucity of genetic tools available hinder our ability to investigate 
mechanisms of adaptation and chemical response.  To adapt existing genetic tools for use 
in this valuable environmental model, we developed and evaluated antisense morpholino 
oligo (MO) gene knockdown methods for use in killifish.  Morpholino oligos are 
chemically modified oligonucleotides (generally 25 bases) that bind to specifically 
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targeted mRNA (Nasevicius and Ekker, 2000).  Morpholinos reduce gene expression via 
steric blocking of translation or pre-mRNA splicing. 
Of the killifish populations known to have adapted to environmental contaminants, 
several have adapted specifically to chemicals that act via AhR-dependent mechanisms, 
and alterations to the AhR pathway seem to be a critical component of the adaptation 
(Prince and Cooper, 1995a, b, Nacci et al., 1999, Powell et al., 2000, Bello et al., 2001, 
Ownby et al., 2002, Meyer and Di Giulio, 2003, Bacanskas et al., 2004, Hahn et al., 
2004).  Specifically, all of these populations exhibit a marked reduction in CYP1A 
inducibility in response to a variety of AhR agonists (Prince and Cooper, 1995a, Elskus et 
al., 1999, Nacci et al., 1999, Bello et al., 2001, Arzuaga and Elskus, 2002, Meyer et al., 
2002, Meyer et al., 2003).  To more fully understand alterations to the AhR pathway, 
CYP1A was chosen as the target for morpholino gene knockdown in killifish from a 
reference site.   
CYP1A is an excellent target gene for assessing the utility of MO technology in 
killifish for several reasons.  First, CYP1A is known to be a critical determinant of 
embryotoxicity caused by PAH mixtures (Wassenberg and Di Giulio, 2004, Billiard et al., 
2006).  Second, we can easily test for protein activity via the in ovo EROD assay.  This is 
particularly important given the inability to use mRNA to quantify the effectiveness of 
MOs that act by inhibiting translation.  Third, knockdown of CYP1A via chemical 
inhibition in Fundulus (Wassenberg and Di Giulio, 2004) or with morpholinos in 
zebrafish (Billiard et al., 2006) has been shown to exacerbate the embryotoxicity of AhR 
agonists and PAH mixtures.  Therefore, we could also use deformity screens to test 
whether the MO gene knockdown was successful.  Finally, immunochemical techniques 
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have been shown to be useful in assessing induced CYP1A protein levels in Fundulus 
embryos (Toomey et al., 2001). 
Antisense morpholino oligo technology has primarily been used in zebrafish 
(Danio rerio) and clawed frogs (Xenopus laevis and X. tropicalis).  While MO based 
experiments are most often conducted in zebrafish, there are several significant 
differences between zebrafish and killifish eggs.  Killifish eggs are larger, have a more 
durable chorion, have higher internal pressure, have mucous-like material on the exterior 
surface of the chorion that can contain large amounts of debris, and develop more slowly 
(Armstrong and Child, 1965, Brummett and Dumont, 1981, Morin and Able, 1983, 
Marteinsdottir and Able, 1988, Taylor, 1999).  Egg size does not pose a significant 
challenge for microinjection of morpholinos; however, the tougher chorion and high 
internal pressure are considerable challenges.  The mucous-like membrane surrounding 
the chorion is a significant problem with regard to clogging injection needles.   
Killifish have a long development time (~14 days) compared to zebrafish (2-3 
days).  The slower developmental rate in killifish can be both an advantage and 
disadvantage.  The several hours that it takes embryos to reach the 8-cell stage allows for 
the injection of large numbers of eggs, but the extended development period greatly 
increases the amount of time a morpholino must remain effective.  Since zebrafish 
develop rapidly, the duration of morpholino effectiveness has not been a primary concern.  
However, reports of successful use of this technology in rainbow trout, Oncorhynchus 
mykiss (Boonanuntanasarn et al., 2002) and sea lamprey, Petromyzon marinus 
(McCauley and Bronner-Fraser, 2006), which have significantly longer development 
times (>2 weeks), suggest that MO usage in killifish would be feasible.  Antisense 
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morpholino oligo technology remains the only thoroughly tested method of in vivo gene 
expression knockdown in fish embryos.  Thus, the development of MO technologies in 
Fundulus would provide a powerful tool for studying gene function in this established 
environmental model.  Subsequent research will make use of this technology to further 
our understanding of the aryl hydrocarbon receptor (AhR) pathway and its role in killifish 
adaptation to PAH-contaminated environments. 
 
 
2.  Materials and Methods 
2.1.  Fish Care 
 Adult killifish were collected at a reference site on King’s Creek, a tributary of 
the James River which feeds into the lower Chesapeake Bay in southeastern Virginia 
(37°17´52.4˝N, 76°25´31.4˝W).  Fish were maintained at 23-25°C in 25 ppt artificial 
seawater (ASW; Instant Ocean, Foster & Smith, Rhinelander, WI) and fed a mixture of 
TetraMin® Tropical Flakes (Tetra, Blacksburg, VA) and freshly hatched brine shrimp 
(Artemia, Brine Shrimp Direct, Ogden, UT).  Eggs were manually collected from females 
and fertilized in vitro by milking sperm from males directly into a beaker containing the 
eggs in ASW.  Eggs were set aside for 30 minutes for fertilization, and then washed in 
0.3% hydrogen peroxide.  Eggs are subsequently “rolled” on durable wet paper towels 
with wet fingers to remove mucous-like material and debris from the exterior of the 
chorion, as per standard medaka egg separation techniques (Marty et al., 1990).  At this 
point the embryos are ready for injection.  Adult care and reproductive techniques are 
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non-invasive and have been reviewed and approved by the Duke University Institutional 
Animal Care & Use Committee (A250-04-09). 
 
2.2.  Morpholino and Microinjection 
Morpholino antisense oligos were designed and manufactured by Gene Tools 
(Philomath, OR).  The CYP1A morpholino was designed to target F. heteroclitus 
cytochrome P4501A (Morrison et al., 1998)(GenBank, AF026800);  the CYP1A MO 
sequence was 5′-ATGCCATGATGACAACTTTTCTCTG-3′.  This morpholino overlaps 
the start codon (underlined) and acts as a translational blocker.  Gene Tools’ standard 
control morpholino (Control MO, 5′-CCTCTTACCTCAGTTACAATTTATA-3′) was 
used as a morpholino injection control.  All morpholinos used were tagged with 
fluorescein to monitor embryonic incorporation.  Morpholinos were diluted to 250 μM 
injection stocks in RNase free water.  Working injection stocks were maintained at 4°C.  
Morpholino injection stocks were briefly vortexed and centrifuged for 5 minutes prior to 
use. 
 Microinjection system consisted of a Nikon SMZ-1500 zoom stereomicroscope 
(Nikon Instruments Inc., Lewisville, TX), MDI PM 1000 Cell Microinjector (MicroData 
Instrument Inc., S. Plainfield, NJ), course manipulator (Narishige International USA, Inc., 
New York, NY), and a three-axis joystick oil hydraulic micromanipulator (Narishige).  A 
PC-10 Puller (Narishige) was used to pull filtered ethanol-rinsed 1.0 mm O.D., 0.5 mm 
I.D., 10 cm borosilicate glass tubing (Sutter Instrument, Novato, CA) into microinjection 
needles using a single pull with a heater output setting of 53.  Embryos were placed in a 
glass Petri dish filled with ASW.  For injections, embryos were immobilized by wedging 
 8
them between a 44.7 μL calibrated “holding” pipette (VWR, West Chester, PA) and the 
bottom of a glass Petri dish.  Eggs were oriented so that the blastodisc was aligned for 
injection directly into the cell.  Morpholino injection volumes ranged from 2-5 nL.  
Injection pressure was varied to compensate for variable needle opening size, thus 
insuring an appropriate injection volume.  Confirmation of proper injection and full 
incorporation was performed immediately following injections and at 24 hpf, respectively, 
using a Leica MZ FLIII fluorescence zoom stereomicroscope (Leica Microsystems Inc., 
Bannockburn, IL) and GFP/FITC filter.  Only normally developing embryos that 
displayed strong uniform fluorescence were included in subsequent dosing experiments. 
 
2.3.  Chemicals and Dosing 
β-naphthoflavone (BNF), benzo[a]pyrene (BaP), ethoxyresorufin, and dimethyl 
sulfoxide (DMSO) were purchased from Sigma-Aldrich (St. Louis, Mo), and 3,3',4,4',5-
pentachlorobiphenyl (PCB126) was purchased from AccuStandard (New Haven, CT).  
BNF, BaP, PCB126, and ethoxyresorufin were all dissolved in DMSO.  Embryo dosing 
was conducted in 25 ppt ASW, with individual embryos being exposed in 10 mL of 
solution in 20-mL glass scintillation vials (VWR).  Ethoxyresorufin was added to all 
exposure vials for a final concentration of 21 μg/L for subsequent EROD assays.  BNF 
exposures were performed at a final concentration of 10 μg/L.  DMSO concentrations 
were held constant at < 0.002% across all experimental groups.  Individual embryos were 
placed in 10 mL of dosing solution from 24 hpf through deformity screening at 144 hpf.  
Morpholino duration experiments were conducted using a sliding window approach.  In 
addition to the standard dosing described above, independent groups of embryos were 
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dosed at 96, 144, 196, or 240 hpf, with CYP1A protein activity assessed 48 hours after 
dosing.  A later larval window was added in view of the fact that morpholino duration 
exceeded the normal 14 day incubation period.  Hatchlings were dosed at 18 dpf and 
screened at 20 dpf.  Although primary dosing was performed with the model AhR agonist 
BNF, we also performed dosing experiments with both BaP (100 μg/L) and PCB126 (1 
μg/L).   
 
2.4.  EROD Assay 
CYP1A activity was measured via an in ovo EROD (7-ethoxyresorufin-O-
deethylase) assay modified from Nacci et al. (1998, 2005).  A detailed description of the 
modified method is provided in Wassenberg and Di Giulio (2004).  This assay quantifies 
the fluorescence of resorufin, the product of CYP1A metabolism of ethoxyresorufin, 
which accumulates in the bi-lobed urinary bladder in Fundulus embryos.  Upon hatching, 
resorufin no longer accumulates in the urinary bladder.  Therefore, an in vivo EROD 
assay was used to measure CYP1A activity in Fundulus larvae.  The in vivo and in ovo 
EROD assays differ only in that resorufin fluorescence is quantified in the gall bladder of 
larvae, rather than the urinary bladder of embryos.  EROD assays were performed 48 
hours after dosing for all time points except the 24 hpf dosing, for which larvae were 
screened 72 hours later.  The in vivo EROD assay required anesthetization of larvae with 
MS-222 (Sigma-Aldrich) and immobilization in 3% methylcellulose for proper 
orientation during quantification (Billiard et al., 2006). 
 
2.5.  Deformity Assessment 
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Embryos were dosed with BNF at 24 hpf as described previously.  Heart 
deformities were scored blind at 144 hpf.  Deformities were scored as 0, 1, or 2.  
Common heart abnormalities with BNF exposure were heart elongation and pericardial 
edema.  This scale represented normal (0), mild deformities (1), and severe deformities 
(2).  Representative images for each deformity class have been included in Figure 4 inset.  
Our distinction between mild and severe deformities is important in that embryos with 
severe heart abnormalities do not hatch, whereas mild deformities prevent hatching in 
roughly one half of affected embryos (data not shown).  However, we do not have data 
regarding the long-term survival of Fundulus with mild heart abnormalities.  Embryos 
scored as a 1 on the deformity scale have a range of heart abnormalities from moderate 
orientation changes to slight elongation of the atrium.   
 
2.6 Confirmation of CYP1A Morpholino Efficacy by In Vitro Protein Synthesis 
The TNT® T7 Quick Coupled Reticulocyte Lysate System (Promega, Madison, 
WI) was used to synthesize [35S]methionine-labeled proteins as per manufacturer 
protocols.  Briefly, 20 μL of T7 TNT Quick Master Mix was combined with 1 μL of 
[35S]methionine (> 1,000 Ci/mmol at 10 mCi/mL), 2 μL FhCYP1A-pBluescript II KS(-) 
(0.5 μg/μL), and adjusted to a final volume of 25 μL with H2O.  To test the efficacy of 
the CYP1A MO, 0.5 μL of a 25 μM stock of the standard control morpholino (Control 
MO) or CYP1A MO was added to the reaction, for a final concentration of 500 nM.  
Mixtures were incubated at 30°C for 30 minutes to allow for sufficient in vitro 
transcription of CYP1A.  To facilitate translation of the membrane-associated CYP1A 
protein, 1 μL of canine pancreatic microsomal membranes (Promega) was added to each 
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reaction and incubated at 30°C for an additional 60 minutes.  Fifteen microliters of the 
labeled protein were resolved by SDS-PAGE.  Fluorography was used to amplify the 
signal and visualize proteins on film.  Densitometric analysis was performed with the 
ImageJ software package (National Institutes of Health, Bethesda, MD). 
 
2.7  Western Blot Analysis 
Whole embryos were homogenized in 2X sample treatment buffer (15 µL of 
buffer per embryo) and proteins were further denatured by boiling samples for 3 minutes.  
Homogenates were centrifuged at 14,000 rpm for 5 minutes.  Equivalent volumes of 
lysate were subjected to SDS-PAGE and blotted to nitrocellulose.  Blots were probed 
with monoclonal antibody 1-12-3 (3 µg/mL) against Stenotomus chrysops (scup) CYP1A 
(Park et al., 1986, Kloepper-Sams et al., 1987).  Blots were subsequently probed with 
goat anti-mouse IgG horseradish peroxidase (Bio-Rad, Hercules, CA) secondary antibody 
(1:1000 dilution).  The blots were visualized on film by enhanced chemiluminescence 
(ECL Plus ™, GE HealthCare, Piscataway, NJ).  Densitometric analysis was performed 
with the ImageJ software package.  The relative densitometric units were determined by 
normalizing the data from PCB-only and PCB plus CYP1A MO treatments to the values 
from DMSO treatments after all densitometric values were adjusted for local background. 
 
2.8  Data Analysis 
All data were analyzed using SPSS ver. 15 (Chicago, IL).  EROD data were not 
normally distributed according to the Kolmogorov-Smirnov test.  As such, EROD data 
were rank transformed and a non-parametric ANOVA was performed to test for 
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differences among treatments.  A Bonferroni-corrected post hoc comparison was 
conducted to determine which pairwise comparisons were statistically significant.  
Deformity data were non-parametric in nature and as such were analyzed similarly to our 
rank transformed EROD data.  Statistical significance was accepted at p ≤ 0.05 for all 
tests.  A curve estimation was also performed to determine which type of curve best fit 
our EROD knockdown duration data.   
 
3.  Results and Discussion 
3.1.  Assessment of Injection Techniques and Morpholino Effectiveness 
 To examine the effectiveness of MOs in Fundulus embryos, we tried using 
standard zebrafish injection techniques, which involve morpholino injection into the yolk 
up to the four cell stage (Nasevicius and Ekker, 2000).  Fluorescence screening of these 
embryos at 24 hpf revealed that the morpholino failed to fully incorporate into the 
embryo; the vast majority of fluorescence was observed distributed throughout the yolk.  
In fact, fluorescence remained in the yolk throughout the 14-16 day incubation period.  
Early hatchlings (18 dpf) still had observable fluorescence in what was left of their yolk, 
clearly showing that yolk-injected morpholino was not efficiently incorporated into the 
developing embryo.  The results of EROD assays used to test for functional knockdown 
of CYP1A activity are shown in Figure 1.  Embryos injected into the yolk with the 
CYP1A MO showed a slight, nonsignificant reduction in BNF-induced CYP1A activity 
relative to non-injected embryos.   
In light of these results showing that the CYP1A MO was ineffective when 
injected into the yolk, we altered our protocols to inject MO directly into the blastomere, 
 13
similar to the technique used to inject MO into Xenopus embryos (Heasman et al., 2000). 
Injections were performed on embryos up to the 4-cell stage, with 4-cell embryos being 
injected into two separate cells.  When morpholino was injected directly into the cell, it 
fully incorporated into the developing embryo.  Fluorescence screening at 24 hpf was 
used to confirm normal embryonic development and full morpholino incorporation.  
Individuals with evenly distributed but minimal fluorescence were evaluated separately 
as “low incorporation” embryos representing a reduced-dose morpholino group.   
CYP1A MO function was tested in cell-injected embryos via an in ovo EROD 
assay.  EROD assay results for high-incorporation embryos demonstrate that the CYP1A 
MO significantly reduced the induction of CYP1A activity in 4 dpf BNF-exposed 
embryos (Fig. 1).  CYP1A activity in BNF-exposed morphants was reduced by 70%, 
relative to non-injected or control morpholino-injected embryos exposed to BNF.  This 
level of knockdown is critical, given that previous work has shown that greater than 50% 
knockdown of CYP1A activity is associated with the synergistic teratogenicity of some 
PAH combinations (Wassenberg and Di Giulio, 2004).  Induction of EROD activity was 
also significantly reduced in low incorporation embryos relative to controls; however, the 
knockdown was not as efficient as seen in the high-incorporation embryos (Fig. 1). 
 
3.2  Confirmation of CYP1A Morpholino Efficacy by In Vitro and In Vivo Analysis  
Reduced EROD induction in CYP1A MO-treated embryos suggested that the MO 
was effective at reducing CYP1A translation in the embryos.  To directly assess the 
effectiveness of the MO, we measured its effect on CYP1A protein synthesis in vitro and 
in vivo.  
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A TNT® assay system was used to confirm the MO efficacy at inhibiting the in 
vitro translation of CYP1A.  Membrane associated proteins do not perform optimally in 
the in vitro TNT reactions (see manufacturer protocols); therefore, microsomal 
membranes were added to the reactions after the initial transcription phase to facilitate 
translation.  Although the protein yield was low compared to non-membrane associated 
proteins, detectable amounts of CYP1A protein were observable by SDS-PAGE of 
[35S]Met-labeled proteins (Figure 2).  Based on densitometric analysis, the CYP1A MO 
was able to inhibit translation by approximately 98% compared to the No MO and Ctrl 
MO control treatments. 
 Western blot analyses were performed to confirm the knockdown of endogenous 
CYP1A protein in Fundulus embryos at various developmental time points.  CYP1A 
protein was not detectable in initial experiments with BNF treated embryos (4 and 6 dpf) 
in which lysate from 6 embryos was loaded in each lane.  Additional gels with lysate 
from 12 embryos per lane allowed for the minimal detection of CYP1A in both DMSO 
controls and BNF treatments but were not sensitive enough to detect any changes in 
protein levels (data not shown).  To optimize detection capabilities, Fundulus embryos 
were exposed to a stronger AHR agonist (PCB126).  While a strong induction of CYP1A 
was observed in 8 dpf embryos exposed to PCB126, CYP1A protein was barely 
detectable in PCB126-exposed embryos injected with the CYP1A MO (Figure 3A).  To 
further assess the degree of inhibition over time, western blot analyses for CYP1A were 
performed on PCB126-treated embryos at 6, 8, and 12 dpf.  Significant decreases in 
induced CYP1A expression (79-86%) were observed in embryos injected with the 
CYP1A MO at these time points (Figure 3B).   
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3.3.  Phenotypic Evaluation of Morpholino Function  
The functionality of the CYP1A MO was also tested in terms of its ability to 
enhance BNF-induced embryotoxicity.  BNF has been shown to cause cardiovascular 
deformities in developing fish embryos at concentrations as low as 10 µg/L (Billiard et al., 
2006).  It has also been demonstrated that reducing CYP1A protein activity, via chemical 
inhibition or morpholino knockdown, during BNF exposures results in increased severity 
of cardiovascular developmental abnormalities in fish embryos (Wassenberg and Di 
Giulio, 2004, Billiard et al., 2006).  We confirmed that 10 µg/L BNF is sufficient to 
induce cardiovascular abnormalities of mild to intermediate severity in Fundulus 
embryos (Fig. 4).  More importantly, the morpholino injected embryos revealed a 
dramatic increase in the number and severity of cardiovascular abnormalities in BNF-
dosed, but not control, groups.  The control morpholino had no observable effect on the 
number or severity of deformities in Fundulus embryos exposed to BNF. 
 
3.4.  Morpholino Functional Duration 
 Functional duration was tested by dosing with BNF and conducting EROD assays 
on embryos at increasing intervals following injection of the CYP1A MO.  In ovo assays 
were performed at two day intervals from 4-12 dpf, and in vivo assays were performed on 
newly hatched Fundulus at 20 dpf.  
Injection of CYP1A-MO at the 1-4-cell stage caused a persistent reduction in 
EROD induction by BNF, with 70% decrease at 4-dpf and a slow recovery of inducibility 
(Fig. 5). In newly hatched Fundulus larvae (20 dpf), BNF-induction of EROD activity 
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was still reduced as compared to control (non-injected) larvae exposed to BNF.  A curve 
estimation was performed to determine which model best fit the data (Fig. 5).  A 
logarithmic model provided the best estimate of mean EROD activity as a function of 
time.  The logarithmic model (Fig. 5) yielded a 10 dpf estimate for the point at which 
CYP1A activity in MO-injected embryos, as measured via EROD assay, was back to 
50% of its normal response, with complete recovery predicted around day 58.   
The longevity of morpholino-induced knockdown is a critical concern of 
scientists using morpholino techniques to study development or processes that only occur 
after a certain developmental stage.  Since development occurs much more slowly in 
Fundulus than in zebrafish, there was some concern that the duration of morpholino 
effects in Fundulus might be insufficient for practical use of this technique.  However, 
these data clearly demonstrate that significant morpholino-induced knockdown lasts 
beyond hatching (~14 dpf), and thus persists throughout the development of all major 
organ systems. In combination, the EROD (Fig. 5) and western blot (Fig. 3) data provide 
a convincing argument for the long duration of morpholino-induced knockdown in 
Fundulus. Thus, it appears that morpholinos will be just as useful in Fundulus as they are 
in zebrafish. 
 
4.  Conclusions 
 We have conclusively shown, via molecular and phenotypic methods, that MO 
technologies can be adapted to the teleost estuarine environmental model, Fundulus 
heteroclitus.  The development and evaluation of MO technologies in Fundulus has 
revealed several critical changes that must be made when working with this species, 
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relative to zebrafish methods.  The hardness of the chorion and high internal pressure 
make the use of an agarose ramp for injection ineffective.  A holding pipette seems to be 
necessary to adequately immobilize Fundulus eggs for proper microinjection, because 
intracellular injections are necessary for proper incorporation of morpholino and thus 
proper alignment of the blastomere is critical.  This has the consequence of slowing down 
the injection process.  However, time is not a critical concern with Fundulus injections, 
given the slower rate of division.  The hardness of the chorion is also important in this 
regard, as non-perpendicular injections often result in broken needles.  We have also 
shown that the duration of MO-mediated gene knockdown in Fundulus is comparable to 
that achieved in zebrafish, in terms of developmental stages during which MO 
knockdown persists.  Gene knockdown continues well into the larval stage, as seen in 
zebrafish.  One additional point to note with regard to morpholino duration is that the 
gene we selected for evaluation of MO technologies in Fundulus (CYP1A) is highly 
inducible (Handley-Goldstone et al., 2005, Timme-Laragy et al., 2007).  As such, it 
provides a very conservative test of morpholino duration.   
The development of MO technologies in Fundulus will allow researchers to more 
fully investigate a number of interesting aspects of killifish, including their adaptation(s) 
to contaminated environments.  The methodology developed here also paves the way for 
complementary methods including RNA rescue, and siRNA, all of which will help 
promote Fundulus as the premier teleost model in environmental biology (see review by 
Burnett et al., 2007). 
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Figure Legends 
Figure 1.  CYP1A activity as measured via in ovo EROD assay for both uninjected 
and morpholino-injected Fundulus embryos.  EROD data are presented as percent 
activity relative to non-injected BNF control.  BNF exposures were conducted at a 
concentration of 10 µg/L, and DMSO was used as a vehicle control.  EROD activity was 
measured in 4 dpf embryos.  Letters above bars represent statistically significant 
groupings (p ≤ 0.05; Bonferroni corrected non-parametric ANOVA).  Cell and yolk 
denotations represent location of morpholino injections.  Low inc. represents cell injected 
embryos that had incomplete or low incorporation of the morpholino. 
 
Figure 2. Inhibition of In Vitro Translation of CYP1A by CYP1A MO.  The ability of 
a CYP1A MO targeting the translation start site for CYP1A to inhibit translation was 
tested via an in vitro translation assay using the TNT® Coupled Reticulocyte System 
(Promega). The standard control MO (Ctrl MO) from Gene Tools was used to detect any 
non-specific interference in the transcriptional/translational process.  A final MO 
concentration of 500 nM was used in each of the reactions.  Densitometric analysis was 
used to calculate percent inhibition of the CYP1A MO compared to No MO (97.7%) or 
Ctrl MO (98.8%). 
 
Figure 3. Inhibition of In Vivo CYP1A Translation by CYP1A MO.  The ability of a 
CYP1A start site MO to inhibit translation in vivo was assessed by western blot analysis 
using lysates from pooled embryos.  A) Representative CYP1A western blot for 8 day 
post fertilized embryos exposed to PCB126 (1 μg/L).  Lysate from 4 embryos was loaded 
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in each lane.  Equal protein loading was confirmed by Ponceau staining of nitrocellulose 
membrane and Coomassie blue staining of SDS-PAGE gels after transfer.  B) 
Densitometric analysis of CYP1A western blots for three different time points during 
Fundulus embryo development.  Percent reduction of CYP1A induction at each time 
point:  6 dpf, 79%; 8 dpf, 82%; 12 dpf, 86%.  Lysate from 6 embryos was loaded in each 
lane.  For each time point, data from PCB-only and PCB+CYP1A-MO-treated embryos 
were normalized to the value for the DMSO control.   
 
Figure 4.  Mean deformity scores for both uninjected and morpholino-injected 
Fundulus embryos.  Increasing deformity score represents increasing severity of 
deformities.  BNF exposures were conducted at a concentration of 10 μg/L, and DMSO 
was used as a vehicle control.  Letters above bars represent statistically significant 
groupings (p ≤ 0.05; Bonferroni corrected non-parametric ANOVA).  Inset contains 
representative images for each deformity class.  Hearts have been traced in white for 
visualization purposes. 
 
Figure 5.  Mean CYP1A activity in CYP1A MO injected embryos in response to 
BNF exposure (10 μg/L), relative to non-injected BNF exposed embryos.  The data 
demonstrate the functional duration of the morpholino in Fundulus embryos.  DMSO was 
used a vehicle control.  Error bars represent standard error of the mean (SEM).  Sample 
sizes are included at the base of each bar.  The logarithmic curve that best explains the 
data is also provided. 
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